Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7389
    +0.0016 (+0.22%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,986.71
    +2,466.70 (+2.64%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ futures

    18,465.00
    -38.75 (-0.21%)
     
  • VOLATILITY

    13.01
    +0.23 (+1.80%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6844
    +0.0039 (+0.57%)
     

Quidel Corp (QDEL) President & CEO Douglas C Bryant Bought $826,500 of Shares

- By insider

President & CEO of Quidel Corp (30-Year Financial, Insider Trades) Douglas C Bryant (insider trades) bought 5,000 shares of QDEL on 02/22/2021 at an average price of $165.3 a share. The total cost of this purchase was $826,500.


Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health, gastrointestinal diseases, and others. Quidel Corp has a market cap of $6.92 billion; its shares were traded at around $163.550000 with a P/E ratio of 8.80 and P/S ratio of 4.29. Quidel Corp had annual average EBITDA growth of 48.90% over the past five years. GuruFocus has detected 2 severe warning signs with Quidel Corp. .

ADVERTISEMENT

CEO Recent Trades:

  • President & CEO Douglas C Bryant bought 5,000 shares of QDEL stock on 02/22/2021 at the average price of $165.3. The price of the stock has decreased by 1.06% since.

For the complete insider trading history of QDEL, click here

.This article first appeared on GuruFocus.